Search Results 991-1000 of 13928 for Assay

  1. Discovery's Edge: Eyes gone bad - Mayo Clinic News Network

    “I do the molecule-based assays, and Mike does the cell-based assays; Keith has the samples and we have the technology to test them," explained Dr. Wieben ...

  2. Clinical trials - Oncology (Medical)

    ... assayed from blood of cases with CAP and controls without history of cancer. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL. Rochester, Minn., Scottsdale/Phoenix ...

  3. Testing Low Dose Tamoxifen For Invasive Breast Cancer, The (LoTam) Trial - Mayo Clinic

    ... assay was obtained, both are required to be low-risk): * Oncotype DX recurrence score ≤ 25 * Mamma Print low risk * Prosigna risk of recurrence ≤ 40 * ...

  4. Publications - Aoife M. Egan, M.B., B.Ch., Ph.D. - Mayo Clinic

    ... assay. Am J Physiol Endocrinol Metab. 2025 Jan 1; 328 (1):E62-E68 Epub 2024 Dec 09. View PubMed; Dunne F, Newman C, Alvarez-Iglesias A, O'Shea P, Devane D ...

  5. Brain Lymphoma Clinical Trials - Mayo Clinic Research

    The Neuro-Oncology Program Registry and Biobank will be used for research purposes to increase our understanding of nervous system tumors. CfDNA Assay ...

  6. A Study To Test The Efficacy, Safety, And Pharmacokinetics Of Rozanolixizumab In Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis - Mayo Clinic

    antibody measured by LGI1 serum autoantibody cell-binding assay. - Study participant must have ≥2 seizures/week during the Screening Period or have

  7. Lung Cancer Screening Clinical Trials - Mayo Clinic Research

    Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery. CASCADE-LUNG: Cancer Screening Assay ...

  8. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HPN217 in Patients with Relaped/Refractory Multiple Myeloma - Mayo Clinic

    Serum free light chain (FLC) assay: Involved FLC level ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (<0.26 or >1.65) 5. Resolved acute effects of ...

  9. NanoString GeoMx Whole Transcriptome Atlas (WTA) - Spatial Multiomics Core - Mayo Clinic Research Core Facilities

    The GeoMx Digital Spatial Profiler platform that the Spatial Imaging Core at Mayo Clinic uses provides whole-transcriptome profiling of human or mouse ...

  10. Publications - Eunhee S. Yi, M.D. - Mayo Clinic

    Reanalysis of the NCCN PD-L1 companion diagnostic assay study for lung cancer in the context of PD-L1 expression findings in triple-negative breast cancer ...